Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith
Japanese pharma company Sawai Pharmaceutical will acquire American generic drug maker Upsher‐Smith Laboratories’s generic pharma business for nearly $1.05bn from Acova. The generic drug portfolio of Upsher-Smith’s portfolio features over 30 pharma products which are primarily oral solid preparations. The transaction marks the first overseas acquisition for Sawai Pharmaceutical as per a report in the […]